Outcomes of oncofertility care in adolescent and young adult cancer patients with Japan Oncofertility Registry which is linked with patient-reported outcomes and national cancer registry
Not Applicable
- Conditions
- cancer, autoimmune diseases
- Registration Number
- JPRN-UMIN000045292
- Lead Sponsor
- Saitama Medical Center, Saitama Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 5000
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who lacked a sense of judgement
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie fertility preservation in adolescent cancer patients with germ cell tumors?
How does oncofertility care in Japan compare to standard-of-care fertility preservation methods in young adult lymphoma patients?
Which biomarkers are associated with successful fertility outcomes in the Japan Oncofertility Registry for breast cancer survivors?
What adverse events are reported in oncofertility interventions for young patients with autoimmune thyroiditis and leukemia?
Are there combination therapies being explored with the Japan Oncofertility Registry for ovarian cancer patients undergoing chemotherapy?